← FDA Drug Approvals (Drugs@FDA)
PEMAZYRE
NDA · New Drug Application · Sponsor: INCYTE CORP · Approved 2020-04-17
Drug application
- FDA Application #
NDA213736- Application type
- New Drug Application
- Brand name
- PEMAZYRE
- Generic name
- PEMIGATINIB
- Active ingredients
- PEMIGATINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- INCYTE CORP
- Manufacturer
- Incyte Corporation
- First approval
- 2020-04-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown